Bladder Cancer Stages, Types, Symptoms and Treatment
Author: Thomas C. Weiss
Published: 2009/04/01 - Updated: 2026/02/16
Publication Type: Informative
Category Topic: Cancer - Tumors - Related Publications
Contents: Synopsis - Introduction - Main - Insights, Updates
Synopsis: This information covers bladder carcinoma in detail, including its primary types such as transitional cell carcinoma, squamous cell carcinoma, and adenocarcinoma, along with the TNM staging system used to classify cancer progression from Stage 0 through Stage 4. Written by a credentialed researcher with a Master's degree and direct experience as a Certified Nursing Assistant providing care to people with disabilities, the article offers a practical breakdown of risk factors, workplace chemical exposure links, diagnostic procedures, surgical and therapeutic treatment options, and key survival statistics. It is particularly relevant for patients, caregivers, seniors, and individuals with disabilities who may qualify for expedited Social Security disability benefits through the SSA's Compassionate Allowance program for advanced bladder cancer cases - Disabled World (DW).
- Topic Definition: Bladder Cancer
Bladder cancer is a malignant disease in which abnormal cells develop within the tissues of the urinary bladder, most commonly originating in the urothelium, the thin layer of transitional cells lining the bladder's interior wall. The most prevalent form is transitional cell carcinoma, which accounts for the majority of diagnoses, while squamous cell carcinoma and adenocarcinoma occur less frequently and are often associated with chronic bladder irritation or long-term inflammation. The disease is staged using the TNM classification system, which evaluates tumor size and depth of invasion, lymph node involvement, and whether cancer has metastasized to distant organs such as the lungs, liver, or bones. Risk factors include occupational exposure to carcinogenic chemicals like arylamines, prior radiation therapy, certain chemotherapy drugs, and chronic bladder infections. Bladder cancer is the fourth most common cancer among men and the ninth most common among women in the United States, making early recognition of symptoms such as hematuria, urinary urgency, and painful urination essential for timely diagnosis and improved treatment outcomes.
Introduction
Bladder Carcinoma: Bladder Cancer Stages and Information
Bladder Carcinoma Alternate Names:
Invasive Bladder Cancer, Bladder Carcinoma, Invasive Bladder Carcinoma, Transitional Cell Carcinoma of the Bladder, Transitional Cell Cancer of the Bladder, Squamous Cell Carcinoma of the Bladder, Squamous Cell Cancer of the Bladder, Adenocarcinoma of the Bladder, Urinary Cancer, Urinary Carcinoma
The U.S. Social Security Administration (SSA) has included Bladder Cancer with distant metastases - inoperable or resectable as a Compassionate Allowance to expedite a disability claim.
Main Content
Bladder cancer is defined as any of several types arising from the urinary bladder's epithelial lining (i.e., the urothelium). Rarely is the bladder involved in non-epithelial cancers, such as lymphoma or sarcoma, but these are not ordinarily included in the colloquial term "bladder cancer." It is a disease in which abnormal cells multiply without control in the bladder. Bladder cancer is a tumor within the bladder, usually starting with the cells lining the bladder walls.
Most bladder cancers are transitional cell carcinomas. Other types include squamous cell carcinoma and adenocarcinoma. The cells that form squamous cell carcinoma and adenocarcinoma develop in the inner lining of the bladder as a result of chronic irritation and inflammation.
Cancer that begins in the transitional cells may spread through the lining of the bladder and invade the bladder's muscle wall or spread to nearby organs and lymph nodes. This is called Invasive Bladder Cancer. These abnormal cells multiply without control.
The tumor may or may not be malignant depending on the invasiveness of the type of cancer. The cause of bladder cancer is uncertain, as with most types of cancer. Studies have shown that several risk factors may contribute to the development of bladder cancer.
About 25 percent of bladder cancer can be attributed to the exposure to cancer-causing chemicals or carcinogens in the workplace. The chemicals that belong to the Arylamines and Benzidine families are considered the most responsible. Arylamines exposure was very high in Dye, Rubber, Aluminum, and Leather industry workers, truck drivers, and pesticide applicators, but most arylamines usage has been reduced in the workplace because of government regulation.
Radiation therapy for women with cervical cancer have an increased risk of developing bladder cancer. Certain drugs, such as chemotherapy agent cyclophosphamide and the analgesic phenacetin, are known to result in a high-risk factor for developing bladder cancer. Repeated or chronic bladder infections may also lead to the type of cancer called squamous cell bladder cancer. This type of bladder cancer is very slow growing, and as with all cancers, early detection can lead to a higher cure rate.
According to the TNM (tumor, lymph node, and metastases) classification system, the cancer stage is classified by location, size, and aggressiveness. Recently the TNM staging system has become very popular in the medical industry to describe all types of cancer.
Stages of Bladder Cancer
The TNM staging system is divided into five main stages and several sub-stages using the following scale.
- Stage 0 - Tumors limited to the bladder lining but did not extend through the bladder wall lining.
- Stage 1 - Tumors involve the layer beyond the lining of the bladder and beyond but do not involve the muscles of the bladder.
- Stage 2 - Tumors involve the muscles in the bladder.
- Stage 3 - Tumors involve the fatty tissue surrounding the bladder, the prostate gland, the vagina, or the uterus.
- Stage 4 - Tumors have spread into the lymph nodes or other body areas such as the liver, lungs, and bones.
The following symptoms of bladder cancer can also be associated with non-cancerous conditions. A trained urologist should always evaluate nerveless any symptom of a suspicious nature. Early detection is critical in the successful outcome of all cancer treatments.
- A medical professional should always be consulted if you have blood in the urine or if the urine becomes cloudy. The color of one's urine does give great insight into the internal condition of the urinary tract.
- Urinary frequency, increased frequency in need to urinate. This could also be a sign of a bladder infection called cystitis, bladder irritation called interstitial cystitis, or a kidney stone.
- Painful urination could also be caused by a bladder infection, kidney stone, or another serious problem.
- Urinary urgency just after using the restroom, and you only urinate small amounts when you do. It could be a bladder infection called cystitis; bladder irritation called interstitial cystitis, or a kidney stone.
Urinary Incontinence
Some women report urinary incontinence after childbirth and may be caused from a weakness in the bladder due to childbirth or aging. This weakness is called stress incontinence - suggested reading kegel exercises and vaginal weight training.
- Common Vitamins and over-the-counter products such as Vitamin A, Cranberry Juice, and L-cysteine can help treat bladder problems.
- Vitamin A deficiency may increase the risk of lung, larynx, bladder, esophagus, stomach, colon, rectum, and prostate cancers.
- Cranberry Juice may also help prevent kidney and bladder infections. If you are taking COUMADIN, check with your doctor before using cranberry.
- L-cysteine is another immune system stimulant. Still, it should always be taken in conjunction with Vitamin C to reduce the risk of developing stone formation in the kidneys and bladder.
The following may be used to diagnose the disease:
- Physical exam and history
- CT scan
- Urinalysis
- Intravenous pyelogram (IVP)
- Cystoscopy (examination of urinary tract),
- Biopsy and urine cytology (microscopic study of cells).
The following may also be used to determine if cancer has spread:
- MRI
- Chest x-ray
- Bone scan
Treatment may include surgery, radiation, chemotherapy, and biologic therapy.
Surgical options may include transurethral resection (TUR), radical cystectomy, segmental cystectomy, and urinary diversion. Some patients may receive chemotherapy after surgery. This post-surgical treatment is referred to as adjuvant therapy. If the cancer is inoperable or unresectable, treatment with radiation and chemotherapy can be utilized for palliation, but the prognosis is poor.
Bladder Cancer Statistics
- The most common type of bladder cancer recapitulates the normal histology of the urothelium and is known as transitional cell carcinoma or, more properly, urothelial cell carcinoma. Five-year survival rates in the United States are around 77%.
- In the United States, bladder cancer is the fourth most common type of cancer in men and the ninth most common cancer in women.
- Globally, in 2010, bladder cancer resulted in 170,000 deaths up from 114,000 in 1990.
- Bladder cancer is the 9th leading cause of cancer, with 430,000 new cases and 165,000 deaths in 2012.
- Bladder cancer is the seventh most common cancer in the UK (around 10,400 people were diagnosed with the disease in 2011), and it is the seventh most common cause of cancer death (around 5,200 people died in 2012).
Insights, Analysis, and Developments
Editorial Note: Bladder cancer remains one of the most commonly diagnosed cancers worldwide, yet early detection continues to be the single most important factor in successful treatment outcomes. With roughly 430,000 new cases reported globally each year and a five-year survival rate of around 77 percent in the United States, awareness of the warning signs - blood in urine, urinary frequency, painful urination, and unexplained urgency - can genuinely save lives. For people living with disabilities and older adults who may already face challenges navigating the healthcare system, understanding the TNM staging process and knowing that advanced cases may qualify for expedited Social Security benefits through the Compassionate Allowance program is critical information that should not be overlooked - Disabled World (DW).
Author Credentials: Thomas C. Weiss is a researcher and editor for Disabled World. Thomas attended college and university courses earning a Masters, Bachelors and two Associate degrees, as well as pursing Disability Studies. As a CNA Thomas has providing care for people with all forms of disabilities. Explore Thomas' complete biography for comprehensive insights into his background, expertise, and accomplishments.